Stock Market Reviews

Read and share opinions on KLTO (Klotho Neurosciences, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mark

Latest News

• Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award
  Nov 7, 2025
• Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston
  Oct 16, 2025
• Klotho Neurosciences Announces Expiration of Letter of Intent
  Oct 7, 2025
• Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership
  Sep 30, 2025
• Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar
  Sep 8, 2025
• Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market
  Aug 18, 2025
• Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology
  Aug 12, 2025
• UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology
  Jul 26, 2025
• Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology
  Jul 24, 2025
• Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets
  Jul 22, 2025
• Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules
  Jul 16, 2025
• Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")
  Jul 10, 2025
• Klotho Neurosciences Begins Manufacture, Prep Work Ahead of Clinical Trials of Potential Sclerosis Therapy
  Jun 30, 2025
• Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS
  Jun 30, 2025
• Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population
  Jun 24, 2025
• KLOTHO NEUROSCIENCES (KLTO) ANNOUNCES MUTUAL TERMINATION OF SHARE EXCHANGE AGREEMENT WITH SKYBELL TECHNOLOGIES (SKYBELL), TO CONTINUE ITS FOCUS ON THERAPEUTICS AND LONGEVITY PROGRAMS
  Jun 18, 2025
• KLOTHO NEUROSCIENCES RAISES OVER $11 MILLION, RETIRES ALL DEBT, AND EXCEEDS NASDAQ STOCKHOLDERS' EQUITY REQUIREMENT
  Jun 16, 2025
• KLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY AND HEALTHY LIFE SPAN - REPLACE A SILENCED GENE CALLED ALPHA-KLOTHO ("α-KLOTHO")
  Jun 9, 2025
• Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco
  Jan 8, 2025